Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M510Revenue (TTM) $M26.4Net Margin (%)-209.3Altman Z-Score-6.7
Enterprise Value $M509EPS (TTM) $-0.8Operating Margin %-184.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-209.3Higher ROA y-yN
Price/Book30210-y EBITDA Growth Rate %-5.7Quick Ratio1.2Cash flow > EarningsY
Price/Sales17.85-y EBITDA Growth Rate %-9.3Current Ratio1.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-56.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-291.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M80.4ROIC % (ttm)-390.1Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BCRX is held by these investors:



BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STAAB THOMAS R IISenior Vice President and CFO 2017-03-20Sell3,250$9.2-31.09view
STAAB THOMAS R IISenior Vice President and CFO 2017-03-10Sell3,250$9.06-30.02view
STAAB THOMAS R IISenior Vice President and CFO 2017-03-08Sell6,500$8.43-24.79view
STAAB THOMAS R IISenior Vice President and CFO 2017-03-06Sell3,250$7.9-19.75view
STAAB THOMAS R IISenior Vice President and CFO 2016-12-19Sell3,250$7.45-14.9view
Barnes Alane PVP, General Counsel & Corp Sec 2016-09-14Sell8,357$4.2748.48view
Babu Yarlagadda SSenior VP - Drug Discovery 2016-08-25Sell30,000$4.0656.16view
BAKER BROS. ADVISORS LP10% Owner 2016-08-16Sell4,046,590$526.8view
STAAB THOMAS R IISenior Vice President and CFO 2016-08-12Sell5,864$5.1822.39view
STAAB THOMAS R IISenior Vice President and CFO 2016-08-09Sell14,577$4.4343.12view

Press Releases about BCRX :

Quarterly/Annual Reports about BCRX:

News about BCRX:

Articles On GuruFocus.com
BioCryst to Announce First Quarter 2017 Financial Results May 4 Apr 24 2017 
BioCryst Expands Development of BCX7353 to Explore Treatment of Acute HAE Attacks Apr 12 2017 
BioCryst Announces Mundipharma Receives Approval for Mundesine® in Japan Apr 03 2017 
BioCryst Pharmaceuticals Prices Public Offering of Common Stock Mar 09 2017 
BioCryst Pharmaceuticals Commences Public Offering of Common Stock Mar 08 2017 
A Trump Presidency May Be Good for Biotech Dec 16 2016 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K/A) Jan 19 2011 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 

More From Other Websites
BioCryst to Announce First Quarter 2017 Financial Results May 4 Apr 24 2017
After announcing a $45M public offering, BioCryst to launch new trial Apr 13 2017
BioCryst Expands Development of BCX7353 to Explore Treatment of Acute HAE Attacks Apr 12 2017
BioCryst to receive royalties from cancer treatment approved in Japan Apr 04 2017
Stocks of companies with Raleigh-Durham area HQ make a comeback in March Apr 03 2017
BioCryst Announces Mundipharma Receives Approval for Mundesine® in Japan Apr 03 2017
BioCryst to Present at the 16th Annual Needham Healthcare Conference Mar 29 2017
Wait for the Pullback on BioCryst Pharmaceuticals Mar 20 2017
Don't Let Offerings Blindside Your Thesis Mar 19 2017
BioCryst Pharmaceuticals (BCRX) Shares March Higher, Can It Continue? Mar 15 2017
It’s time to vaccinate your investments against a deadly bird flu Mar 14 2017
BioCryst Pharmaceuticals Prices Public Offering of Common Stock Mar 09 2017
Biotech Premarket Movers: Spectrum, BioCryst, Curis Mar 09 2017
The Reason Behind BioCryst Pharmaceuticals, Inc.'s 12% Pop Higher Mar 08 2017
BioCryst Pharmaceuticals Commences Public Offering of Common Stock Mar 08 2017
Adamis (ADMP) Shows Strength: Stock Gains 6.7% in Session Mar 08 2017
BioCryst Pharmaceuticals, Inc. :BCRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Mar 07 2017
Biotech's Outlook Strengthens After President Trump's Speech: Today's Reports on Sarepta... Mar 03 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)